Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
10/2010
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010CN101863861A Simple and efficient method for preparing paclitaxel analogue Larotaxel
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/14/2010US20100261696 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113182A1 Intermediates in the preparation of 1,4-diphenyl azetidinone
10/07/2010US20100256395 Efficient method for producing mugineic acids
10/07/2010CA2757722A1 Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
10/06/2010EP2234966A2 Azetidine derivatives, their preparation and their application in therapy
09/2010
09/30/2010WO2009157019A3 Process for preparing ezetimibe using novel allyl intermediates
09/30/2010US20100249096 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/30/2010US20100249091 Amide Compounds Useful in Therapy
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/29/2010CN101845010A Method for preparing ezetimble
09/29/2010CN101298430B Synthetic method of (2S, 3S)-2-[(carbamoyloxy) methyl]-3-amido-4-oxoazetidinone-1-sulfonate
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803839 Azetidines as MEK inhibitors for the treatment of proliferative diseases
09/22/2010EP2229355A1 Method for preparing azetidine derivatives
09/22/2010CN101838230A Ertapenem separation and purification method
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/10/2010WO2010071358A3 Method of preparing ezetimibe and intermediates used therein
09/08/2010CN101172962B Synthetic intermediate for carbapenem compound for oral administration
09/08/2010CN101048369B Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
09/07/2010US7790907 Producing low temperature tolerant, storage stable polymerization intermediates; catalytic 4,4'-diphenylmethane diisocyanate conversion
09/07/2010US7790707 S1P receptor modulating compounds and use thereof
09/07/2010CA2509218C 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
09/02/2010WO2010097350A1 A process for the preparation of an aldehyde beta-lactam compound
09/02/2010US20100222600 Azetidine compounds as orexin receptor antagonists
09/02/2010US20100222320 Triazole derivatives for treating alzheimer's disease and related conditions
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
08/2010
08/31/2010US7786104 vanilloid receptor antagonists such as N-{6-[((R)-3-tert-Butoxycarbonylamino)pyrrolidin-1-yl]pyridin-3-yl}-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide, used as analgesics, antidepressants, antidiabetic agents, and for the treatment of gastrointestinal disorders or neurodegenerative diseases
08/31/2010US7786103 Method for isolating an intestinal cholesterol binding protein
08/26/2010US20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
08/26/2010US20100216761 Novel azetidinones useful as inhibitors of elastase
08/26/2010US20100216759 Novel 2-Azetidinone Derivatives And Their Use As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemia
08/25/2010EP2220040A1 New crystalline diphenyl acetidinone hydrate, pharmaceutical agent containing said compound and use thereof
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010CN101157647B Method for synthesizing carbapenem antibiotic medicine intermediate
08/24/2010US7781590 2-(methylamino)-2-oxoethyl 2-[1-(biphenyl-4-ylmethyl)piperidin-4-yl]ethylcarbamate; interacting with cannabinoid and vanilloid receptors; preparation by aminolysis of a 3-(2-piperidin-4-ylethyl)-1,3-oxazolidine-2,4-dione
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010US20100210623 Therapeutic compounds
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c
08/17/2010US7777054 Reduced color via hindered amino ether; quenching; 4,4'-diphenylmethane diisocyanate (MDI) and catalyst for reaction of isocyanate groups to form carbodiimides that undergo further reaction to form uretonimine oligomers; storage stability
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/10/2010US7772429 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
08/10/2010US7772251 N-sulphonylated amino acid derivatives, method for the production and use thereof
08/10/2010US7772223 Carboxamide derivatives as muscarinic receptor antagonists
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087159A1 Method of producing organic compound having carboxyl group, hydroxy group, and carboxylic acid derivative in same molecule
08/04/2010EP2212281A1 Arylsulfonamides with analgesic activity
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
07/2010
07/29/2010WO2010083570A1 Novel metabolic disease therapy
07/29/2010US20100190764 Novel compounds
07/28/2010EP2209372A1 Novel azetidinones useful as inhibitors of elastase
07/28/2010CN1940080B Synthesis of (2S,3R)-2-aminomethyl-3-hydroxy-butyrate by (2R,3S)-2-benzoylaminometh-3-hydroxy-butyrate ester
07/28/2010CN1932025B Industrial production process of 3R, 4R-3-[(1R)-tert-butyl dimethyl siloxane ethyl]-4-acetoxyl-2-azetinone
07/28/2010CN101785772A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
07/27/2010US7763597 Salts
07/22/2010US20100184997 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
07/20/2010US7759335 Cardiometabolic disorders like obesity, diabetes, hypertension and dyslipidemias, 3, 4-diarylpyrazole derivatives; highly selective; limited or no CNS adverse side effects, including mood disorders
07/15/2010WO2010080455A1 New salts
07/15/2010WO2010080409A1 Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid
07/15/2010WO2010080398A1 Sulfonamides as trpm8 modulators
07/15/2010CA2747662A1 Sulfonamides as trpm8 modulators
07/15/2010CA2747558A1 New salts
07/15/2010CA2747437A1 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid
07/13/2010US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
07/07/2010CN101768101A Method for preparing 4-acetoxy-2-azetidinone
07/01/2010WO2010074088A1 Cyclic amine compounds
07/01/2010US20100168414 Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof
07/01/2010US20100168079 Biaryl Benzylamine Derivatives
07/01/2010US20100168075 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
07/01/2010CA2748249A1 Cyclic amine compounds
06/2010
06/30/2010EP2202223A1 Heterocyclic compound
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010CN101765587A 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
06/30/2010CN101759604A Guanidyl substitutional tetracycline derivative
06/30/2010CN101759598A Tetracycline compound with amino acid amidine
06/29/2010US7745643 chemical synthesizing a N-(haloacetyl)-3,3-dinitro-azetidine compound; anticarciogenic, antiinflammatory, antihypoxic, antidiabetic agent; cardiovascular and autoimmune disease; rheumatoid arthritis, diabetic retinopathy
06/29/2010US7745565 Azetidine derivatives, method for producing said derivatives and use thereof
06/24/2010WO2010071794A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
06/24/2010WO2010071358A2 Method of preparing ezetimibe and intermediates used therein
06/24/2010WO2008096372A3 Process for preparing highly pure ezetimibe using novel intermediates
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/24/2010US20100160285 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
06/24/2010US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 69